• CAS
  • |
  • C&EN
  • |
  • Journals
  • |
  • ACS

search site
Advanced Search »
  • Home
  • |
  • About CAS
    • CAS Media Library
    • CAS Quotes
    • Colors of Chemistry
    • 100th Anniversary Celebration
    • Careers at CAS
    • FAQs
    • Directions to CAS
    • Contact Us
  • |
  • Our Expertise
    • CAS Databases
    • Value Added Tools
    • Technical Service and Support
  • |
  • Solutions
    • Researchers
    • IP Professionals
    • Information Professionals
    • Academics
  • |
  • Products & Services
    • SciFinder
    • STN Family of Products
    • Science IP
    • CAS Client Services
    • CAS Document Detective Service
    • CD Products
    • Print Products
  • |
  • Support & Training
    • SciFinder
    • SciFinder Scholar
    • STN
    • STN Express
    • STN AnaVist
    • STN Viewer
    • STN on the Web
    • STN Easy
    • CAS Customer Care
  • |
  • News & Events
    • What's New
    • Press Room
    • News Releases
    • In the News
    • Trade Shows
  • CAS Science Spotlight Home
  • About
  • What's New
Home   •   Spotlight  •  medsci01  •  Most Cited Journal Articles 2001-Medical Sciences (6)
Most Cited Journal Articles 2001-Medical Sciences

spotlightlogo.gif

Following is a CAS database record representing a highly cited journal article.


CAS subject entries for this document include: Phosphoproteins; Ribonucleic acid formation factors .

CAPLUS COPYRIGHT 2002 ACS

TITLE: The NF-.kappa.B and I.kappa.B proteins: new discoveries and insights
AUTHOR(S): Baldwin, Albert S., Jr.
CORPORATE SOURCE: Department Biology, University North Carolina, Chapel Hill, NC, 27599, USA
SOURCE: Annual Review of Immunology (1996), 14, 649-81 CODEN: ARIMDU; ISSN: 0732-0582
PUBLISHER: Annual Reviews
LANGUAGE: English
ABSTRACT:
A review, with 180 refs. The transcription factor NF-.kappa.B has attracted widespread attention among researchers in many fields based on the following: its unusual and rapid regulation, the wide range of genes that it controls, its central role in immunol. processes, the complexity of its subunits, and its apparent involvement in several diseases. A primary level of control for NF-.kappa.B is through interactions with an inhibitor protein called I.kappa.B. Recent evidence confirms the existence of multiple forms of I.kappa.B that appear to regulate NF-.kappa.B by distinct mechanisms. NF-.kappa.B can be activated by exposure of cells to LPS or inflammatory cytokines such as TNF or IL-1, viral infection or expression of certain viral gene products, UV irradn., B or T cell activation, and by other physiol. and nonphysiol. stimuli. Activation of NF-.kappa.B to move into the nucleus is controlled by the targeted phosphorylation and subsequent degrdn. of I.kappa.B. Exciting new research has elaborated several important and unexpected findings that explain mechanisms involved in the activation of NF-.kappa.B. In the nucleus, NF-.kappa.B dimers bind to target DNA elements and activate transcription of genes encoding proteins involved with immune or inflammation responses and with cell growth control. Recent data provide evidence that NF-.kappa.B is constitutively active in several cell types, potentially playing unexpected roles in regulation of gene expression. In addn. to advances in describing the mechanisms of NF-.kappa.B activation, excitement in NF-.kappa.B research has been generated by the first report of a crystal structure for one form of NF-.kappa.B, the first gene knockout studies for different forms of NK-.kappa.B and of I.kappa.B, and the implications for therapies of diseases thought to involve the inappropriate activation of NF-.kappa.B.

Updated 4/19/2007 8:26:12 AM
Home  |  About CAS  |  Our Expertise  |  Solutions  |  Products & Services  |  Support  |  News & Events
Copyright © 2008 American Chemical Society